Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Preferred Stock Liabilities: 2012-2019

Historic Preferred Stock Liabilities for UNITED THERAPEUTICS (UTHR) over the last 6 years, with Jun 2019 value amounting to $8.4 million.

  • UNITED THERAPEUTICS's Preferred Stock Liabilities fell 56.25% to $8.4 million in Q2 2019 from the same period last year, while for Jun 2019 it was $8.4 million, marking a year-over-year decrease of 56.25%. This contributed to the annual value of $19.2 million for FY2018, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q2 2019, UNITED THERAPEUTICS's Preferred Stock Liabilities is $8.4 million, which was down 56.25% from $19.2 million recorded in Q1 2019.
  • UNITED THERAPEUTICS's 5-year Preferred Stock Liabilities high stood at $20.4 million for Q1 2015, and its period low was $8.4 million during Q2 2019.
  • In the last 3 years, UNITED THERAPEUTICS's Preferred Stock Liabilities had a median value of $19.2 million in 2019 and averaged $17.3 million.
  • In the last 5 years, UNITED THERAPEUTICS's Preferred Stock Liabilities tumbled by 66.60% in 2015 and then surged by 76.15% in 2017.
  • UNITED THERAPEUTICS's Preferred Stock Liabilities (Quarterly) stood at $11.1 million in 2015, then fell by 1.80% to $10.9 million in 2016, then soared by 76.15% to $19.2 million in 2017, then remained steady at $19.2 million in 2018, then tumbled by 56.25% to $8.4 million in 2019.
  • Its Preferred Stock Liabilities stands at $8.4 million for Q2 2019, versus $19.2 million for Q1 2019 and $19.2 million for Q4 2018.